RUSSO, ANTONIO
 Distribuzione geografica
Continente #
EU - Europa 381
NA - Nord America 304
AS - Asia 68
AF - Africa 2
Totale 755
Nazione #
US - Stati Uniti d'America 303
IE - Irlanda 204
IT - Italia 79
SG - Singapore 34
FR - Francia 26
GB - Regno Unito 24
CN - Cina 18
DE - Germania 18
GR - Grecia 11
FI - Finlandia 8
KR - Corea 6
NL - Olanda 6
HK - Hong Kong 4
RS - Serbia 3
BD - Bangladesh 2
CD - Congo 2
SE - Svezia 2
CA - Canada 1
ID - Indonesia 1
IN - India 1
IR - Iran 1
TR - Turchia 1
Totale 755
Città #
Dublin 204
Ashburn 39
Naples 30
New York 23
Chandler 22
Singapore 22
Princeton 16
Roxbury 16
Cambridge 14
Bremen 13
Washington 11
Jacksonville 9
Amsterdam 6
Seoul 6
Boardman 5
Lappeenranta 5
Los Angeles 5
Redwood City 5
Caserta 4
Hong Kong 4
Jinan 4
Milan 4
Paris 4
Ariano Irpino 3
Beijing 3
Belgrade 3
Des Moines 3
Helsinki 3
Bonea 2
Chittagong 2
Kinshasa 2
Marco 2
Medford 2
Monza 2
Munich 2
Rome 2
Seattle 2
Aci Sant'Antonio 1
Alpharetta 1
Athens 1
Aydin 1
Bergamo 1
Boydton 1
Busto Arsizio 1
Casoria 1
Cava de' Tirreni 1
Hangzhou 1
Hebei 1
Henderson 1
Houston 1
Hyderabad 1
Kingston 1
London 1
Miami 1
Palagiano 1
Perugia 1
Portici 1
Rio Saliceto 1
Salerno 1
San Giorgio a Cremano 1
San Giuseppe Vesuviano 1
San Lazzaro di Savena 1
Shenyang 1
Stockholm 1
Wilmington 1
Zanjan 1
Totale 533
Nome #
Abacavir hypersensivity reaction (HSR), associated to baseline false negative HLAB5701 screening, in antiretroviral treatment naive HIV-1 patient. 71
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 41
Reazione di ipersensibilità ad abacavir associata a test HLAB5701 falsamente negativo al basale, in paziente HIV naive al trattamento antiretrovirale. 39
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 36
RISK OF FAILURE IN DUAL THERAPY VERSUS TRIPLE THERAPY IN NAÏVE HIV-PATIENTS: A META-ANALYSIS 34
An estimation of the prevalence of occult HBV infection in Western Europe and in Northern America: A meta-analysis 33
Delirium and Psychiatric Sequelae Associated to SARS-CoV-2 in Asymptomatic Patients With Psychiatric History and Mild Cognitive Impairment as Risk Factors: Three Case Reports 33
null 32
Efficacy of 12-weeks velpatasvir plus sofosbuvir-based regimen in HCV-naive subjects with mild fibrosis: A meta-analysis 29
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 28
Epidemiological and etiological variations in hepatocellular carcinoma 28
Hbv/hdv co‐infection: Epidemiological and clinical changes, recent knowledge and future challenges 26
Innovative procedures for micro-elimination of HCV infection in persons who use drugs 25
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study 23
Prevalence of occult HBV infection in Western countries 23
Hepatitis C virus (HCV) micro-elimination in the hospital setting: The results of the HCV Caserta hospital project 22
Impact of an education‐based antimicrobial stewardship program on the appropriateness of antibiotic prescribing: Results of a multicenter observational study 21
Inappropriateness of Antibiotic Prescribing in Medical, Surgical and Intensive Care Units: Results of a Multicentre Observational Study 20
Risk of failure in dual therapy versus triple therapy in naïve HIV patients: a systematic review and meta-analysis 20
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 19
Blood donor serological screening for SARS-CoV-2 as a tool to estimate the prevalence of asymptomatic infection in a low-intermediate endemic area of southern Italy after the first wave of the pandemic 19
Standard versus high dose of rifampicin in the treatment of pulmonary tuberculosis: a systematic review and meta-analysis 19
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 18
Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study 17
Current status of laboratory diagnosis for covid-19: A narrative review 16
Burden, risk assessment, surveillance and management of SARS-CoV-2 infection in health workers: A scoping review 16
Different Clinical Outcomes of COVID-19 in Two Healthcare Workers Vaccinated with BNT162b2 Vaccine, Infected with the Same Viral Variant but with Different Predisposing Conditions for the Progression of the Disease 14
Prognostic Value of Transaminases and Bilirubin Levels at Admission to Hospital on Disease Progression and Mortality in Patients with COVID-19—An Observational Retrospective Study 12
Evaluation of Lipid Profile and Intima Media Thickness in Antiretroviral-Experienced HIV-Infected Patients Treated with Protease Inhibitor-Based Regimens versus Protease Inhibitor-Sparing Regimens 10
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 9
Prognostic Value of Creatinine Levels at Admission on Disease Progression and Mortality in Patients with COVID-19-An Observational Retrospective Study 8
Obesity as a Risk Factor of Severe Outcome of COVID-19: A Pair-Matched 1:2 Case-Control Study 7
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 7
Pre-existing chronic kidney disease (CDK) was not associated with a severe clinical outcome of hospitalized COVID-19: results of a case-control study in Southern Italy 6
Clinical Characterization of the Three Waves of COVID-19 Occurring in Southern Italy: Results of a Multicenter Cohort Study 6
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial 5
Clinical and epidemiological factors causing longer SARS-CoV 2 viral shedding: the results from the CoviCamp cohort 4
Clinical features of patients with home isolation SARS-COV-2 infection: A multicenter retrospective study in southern Italy 2
Efficacy of sotrovimab on omicron BA.2, BA.4 and BA.5 subvariants of sars-cov-2 vs. other early therapies: a systematic review and meta-analysis of literature data 1
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort 1
Totale 800
Categoria #
all - tutte 5.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 4 0 0 1 7 7 1 0 2 0
2020/202142 0 0 2 1 12 6 3 8 0 0 10 0
2021/202276 1 0 2 0 21 0 9 1 1 3 4 34
2022/2023313 20 5 6 3 43 25 2 10 169 5 11 14
2023/2024304 19 10 35 30 94 46 4 6 8 6 7 39
2024/202520 1 11 8 0 0 0 0 0 0 0 0 0
Totale 800